ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $262,000 | -12.7% | 5,903 | -23.0% | 0.00% | -50.0% |
| Q2 2018 | $300,000 | +7.1% | 7,663 | +97.7% | 0.00% | 0.0% |
| Q1 2018 | $280,000 | -14.9% | 3,876 | -22.3% | 0.00% | 0.0% |
| Q4 2017 | $329,000 | +31.6% | 4,991 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $250,000 | -21.1% | 4,991 | -27.2% | 0.00% | -50.0% |
| Q2 2017 | $317,000 | +24.8% | 6,854 | -4.6% | 0.00% | 0.0% |
| Q1 2017 | $254,000 | +59.7% | 7,188 | -43.4% | 0.00% | +100.0% |
| Q4 2016 | $159,000 | -11.2% | 12,691 | +19.7% | 0.00% | 0.0% |
| Q1 2016 | $179,000 | -40.7% | 10,599 | +187.2% | 0.00% | -50.0% |
| Q2 2015 | $302,000 | -0.3% | 3,691 | +12.7% | 0.00% | 0.0% |
| Q1 2015 | $303,000 | +106.1% | 3,276 | -69.4% | 0.00% | +100.0% |
| Q4 2013 | $147,000 | – | 10,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |